Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of 6.11 billion. The enterprise value is 7.37 billion.
Market Cap | 6.11B |
Enterprise Value | 7.37B |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | May 1, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.37% |
Shares Change (QoQ) | -0.58% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 849.31M |
Valuation Ratios
The trailing PE ratio is 31.54.
PE Ratio | 31.54 |
Forward PE | n/a |
PS Ratio | 0.97 |
PB Ratio | 5.86 |
P/TBV Ratio | 8.58 |
P/FCF Ratio | 25.18 |
P/OCF Ratio | 13.57 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.51, with an EV/FCF ratio of 30.37.
EV / Earnings | 38.04 |
EV / Sales | 1.08 |
EV / EBITDA | 10.51 |
EV / EBIT | 17.85 |
EV / FCF | 30.37 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 1.19.
Current Ratio | 1.38 |
Quick Ratio | 0.41 |
Debt / Equity | 1.19 |
Debt / EBITDA | 1.92 |
Debt / FCF | 5.13 |
Interest Coverage | 2.86 |
Financial Efficiency
Return on equity (ROE) is 19.39% and return on invested capital (ROIC) is 10.81%.
Return on Equity (ROE) | 19.39% |
Return on Assets (ROA) | 6.97% |
Return on Invested Capital (ROIC) | 10.81% |
Return on Capital Employed (ROCE) | 18.23% |
Revenue Per Employee | 97,035 |
Profits Per Employee | 2,990 |
Employee Count | 64,758 |
Asset Turnover | 1.84 |
Inventory Turnover | 3.50 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.84% in the last 52 weeks. The beta is 0.24, so Raia Drogasil's price volatility has been lower than the market average.
Beta (5Y) | 0.24 |
52-Week Price Change | -28.84% |
50-Day Moving Average | 3.34 |
200-Day Moving Average | 4.26 |
Relative Strength Index (RSI) | 52.01 |
Average Volume (20 Days) | 1,213 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of 6.28 billion and earned 193.65 million in profits. Earnings per share was 0.12.
Revenue | 6.28B |
Gross Profit | 1.87B |
Operating Income | 380.77M |
Pretax Income | 228.90M |
Net Income | 193.65M |
EBITDA | 494.93M |
EBIT | 380.77M |
Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 87.91 million in cash and 1.24 billion in debt, giving a net cash position of -1.16 billion.
Cash & Cash Equivalents | 87.91M |
Total Debt | 1.24B |
Net Cash | -1.16B |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.04B |
Book Value Per Share | 0.61 |
Working Capital | 562.70M |
Cash Flow
In the last 12 months, operating cash flow was 450.08 million and capital expenditures -207.55 million, giving a free cash flow of 242.53 million.
Operating Cash Flow | 450.08M |
Capital Expenditures | -207.55M |
Free Cash Flow | 242.53M |
FCF Per Share | n/a |
Margins
Gross margin is 29.72%, with operating and profit margins of 6.06% and 3.08%.
Gross Margin | 29.72% |
Operating Margin | 6.06% |
Pretax Margin | 3.64% |
Profit Margin | 3.08% |
EBITDA Margin | 7.88% |
EBIT Margin | 6.06% |
FCF Margin | 3.86% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 1.30%.
Dividend Per Share | 0.05 |
Dividend Yield | 1.30% |
Dividend Growth (YoY) | 12.93% |
Years of Dividend Growth | n/a |
Payout Ratio | 39.62% |
Buyback Yield | 2.37% |
Shareholder Yield | 3.67% |
Earnings Yield | 3.17% |
FCF Yield | 3.97% |
Stock Splits
The last stock split was on October 1, 2020. It was a forward split with a ratio of 5.
Last Split Date | Oct 1, 2020 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Raia Drogasil has an Altman Z-Score of 4.15.
Altman Z-Score | 4.15 |
Piotroski F-Score | n/a |